Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bibuvit
- Development stage
- Unknown
- Lead developer
- Sunlife
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Bibuvit is a multivitamin supplement developed and manufactured by Sunlife Pharmaceuticals. It is formulated as a combination of B-complex vitamins, typically including thiamine (B1), riboflavin (B2), niacinamide (B3), pyridoxine (B6), and cyanocobalamin (B12), often enriched with the essential amino acid L-lysine. The supplement is designed to prevent or treat vitamin deficiencies, support energy metabolism, and promote healthy growth and development, particularly in pediatric and geriatric populations. As a branded generic product, it is marketed for general health maintenance and as an adjunct in the recovery from illness.
- Brand names
- Bibuvit
- Other names
- Bibuvit SyrupBibuvit Tablet
Beyond the preview
Go deeper on Bibuvit.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bibuvit.